Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.
The ectodomain of the matrix 2 protein (M2e) of influenza A virus represents an attractive target for developing a universal influenza A vaccine, with its sequence being highly conserved amongst human variants of this virus. With the aim of targeting conformational epitopes presumably shared by dive...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9fcc58fe31204fd5913bf95deb263eb9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9fcc58fe31204fd5913bf95deb263eb9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9fcc58fe31204fd5913bf95deb263eb92021-11-18T08:13:33ZIncreased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein.1932-620310.1371/journal.pone.0046395https://doaj.org/article/9fcc58fe31204fd5913bf95deb263eb92012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23049700/?tool=EBIhttps://doaj.org/toc/1932-6203The ectodomain of the matrix 2 protein (M2e) of influenza A virus represents an attractive target for developing a universal influenza A vaccine, with its sequence being highly conserved amongst human variants of this virus. With the aim of targeting conformational epitopes presumably shared by diverse influenza A viruses, a vaccine (M2e-NSP4) was constructed linking M2e (in its consensus sequence) to the rotavirus fragment NSP4(98-135); due to its coiled-coil region this fragment is known to form tetramers in aqueous solution and in this manner we hoped to mimick the natural configuration of M2e as presented in membranes. M2e-NSP4 was then evaluated side-by-side with synthetic M2e peptide for its immunogenicity and protective efficacy in a murine influenza challenge model. Here we demonstrate that M2e fused to the tetramerizing protein induces an accelerated, augmented and more broadly reactive antibody response than does M2e peptide as measured in two different assays. Most importantly, vaccination with M2e-NSP4 caused a significant decrease in lung virus load early after challenge with influenza A virus and maintained its efficacy against a lethal challenge even at very low vaccine doses. Based on the results presented in this study M2e-NSP4 merits further investigation as a candidate for or as a component of a universal influenza A vaccine.Anne-Marie Carola AnderssonKjell O HåkanssonBenjamin Anderschou Holbech JensenDennis ChristensenPeter AndersenAllan Randrup ThomsenJan Pravsgaard ChristensenPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 10, p e46395 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Anne-Marie Carola Andersson Kjell O Håkansson Benjamin Anderschou Holbech Jensen Dennis Christensen Peter Andersen Allan Randrup Thomsen Jan Pravsgaard Christensen Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein. |
description |
The ectodomain of the matrix 2 protein (M2e) of influenza A virus represents an attractive target for developing a universal influenza A vaccine, with its sequence being highly conserved amongst human variants of this virus. With the aim of targeting conformational epitopes presumably shared by diverse influenza A viruses, a vaccine (M2e-NSP4) was constructed linking M2e (in its consensus sequence) to the rotavirus fragment NSP4(98-135); due to its coiled-coil region this fragment is known to form tetramers in aqueous solution and in this manner we hoped to mimick the natural configuration of M2e as presented in membranes. M2e-NSP4 was then evaluated side-by-side with synthetic M2e peptide for its immunogenicity and protective efficacy in a murine influenza challenge model. Here we demonstrate that M2e fused to the tetramerizing protein induces an accelerated, augmented and more broadly reactive antibody response than does M2e peptide as measured in two different assays. Most importantly, vaccination with M2e-NSP4 caused a significant decrease in lung virus load early after challenge with influenza A virus and maintained its efficacy against a lethal challenge even at very low vaccine doses. Based on the results presented in this study M2e-NSP4 merits further investigation as a candidate for or as a component of a universal influenza A vaccine. |
format |
article |
author |
Anne-Marie Carola Andersson Kjell O Håkansson Benjamin Anderschou Holbech Jensen Dennis Christensen Peter Andersen Allan Randrup Thomsen Jan Pravsgaard Christensen |
author_facet |
Anne-Marie Carola Andersson Kjell O Håkansson Benjamin Anderschou Holbech Jensen Dennis Christensen Peter Andersen Allan Randrup Thomsen Jan Pravsgaard Christensen |
author_sort |
Anne-Marie Carola Andersson |
title |
Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein. |
title_short |
Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein. |
title_full |
Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein. |
title_fullStr |
Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein. |
title_full_unstemmed |
Increased immunogenicity and protective efficacy of influenza M2e fused to a tetramerizing protein. |
title_sort |
increased immunogenicity and protective efficacy of influenza m2e fused to a tetramerizing protein. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2012 |
url |
https://doaj.org/article/9fcc58fe31204fd5913bf95deb263eb9 |
work_keys_str_mv |
AT annemariecarolaandersson increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein AT kjellohakansson increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein AT benjaminanderschouholbechjensen increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein AT dennischristensen increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein AT peterandersen increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein AT allanrandrupthomsen increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein AT janpravsgaardchristensen increasedimmunogenicityandprotectiveefficacyofinfluenzam2efusedtoatetramerizingprotein |
_version_ |
1718422062584823808 |